On July 24, Tenet Healthcare rose 12.04% in pre-market trading, trading at $223.0/share, with Turnover of $3,115.95. The surge was driven by the company's Q2 earnings release, which significantly exceeded market expectations on both top and bottom lines.

Tenet reported Q2 adjusted EPS of $6.12, beating the analyst consensus estimate of $4.23 by 44.68% and representing a 52.24% year-over-year increase from $4.02. Revenue for the quarter rose to $5.628 billion from $5.27 billion a year earlier, surpassing the $5.43 billion estimate. The company simultaneously raised its full-year guidance, now expecting adjusted diluted EPS of $20.30 to $21.69, well above the prior analyst consensus of $17.94, with revenue guidance of $21.9 billion to $22.5 billion. This marks a substantial upward revision from the company's earlier guidance range of $16.38 to $18.68 issued after Q1 results.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)